Abstract
Enantioselective antibodies can separate the enantiomers of a chiral
compound in a highly specific manner. We have recently reported the cloning
and applications of a recombinant Fab-fragment, ENA11His, in the
enantioseparation of a drug candidate, finrozole, which contains two chiral
centers. Here, the crystal structures of this enantioselective antibody
Fab-fragment are determined in the absence of the hapten at a resolution of
2.75 Å, and in the presence of the hapten at 2.05 Å resolution. The
conformation of the protein was found to be similar in both free and complex
forms. The hapten molecule was tightly bound in a deep cleft between the light
and heavy chains of the Fab-fragment. The complex structure also allowed us
to describe the molecular basis for enantioselectivity and to deduce the
absolute configurations of all the four different stereoisomers (a–d) of
finrozole. The ENA11His antibody fragment selectively binds the SR (a)
enantiomer from the racemic mixture of a and d-enantiomers, thus allowing
separation from the pharmacologically most active RS enantiomer (d). In
particular, Asp95 and Asn35 of the H-chain in the ENA11 His antibody seem to
provide this specificity through hydrogen bonding.
Original language | English |
---|---|
Pages (from-to) | 471-480 |
Journal | Journal of Molecular Biology |
Volume | 357 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2006 |
MoE publication type | A1 Journal article-refereed |
Keywords
- enantioselective antibody
- Fab-fragment
- complex
- crystal structure
- finrozole